DSCAM and lung carcinoma: In lung cancer, about 1/5 (93 of 488) LUAD samples showed high expression of DSCAM-AS1 (FPKM>2), but the expression level in lung squamous cell carcinoma (LUSC) was very low (only 2 of 230 patients FPKM>2, Figure S1B).